ResMed (RMD) earnings

Earnings (net income) · fiscal 2026
$1.52B

ResMed (RMD) reported net income of $1.52B in fiscal 2026 (the year ended June 30, 2026). That is 8.8% higher than the $1.40B of fiscal 2025. Figures as of 18 Nov 2026, 03:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2026
$1.52B
Change on fiscal 2025
+8.8%
Growth, 5 years
+26.3% a year
Growth, 10 years
+15.8% a year
Highest on record
$1.52Bfiscal 2026
Lowest on record
$146.45Mfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed earnings, in more detail

Over the five fiscal years to 2026 net income grew at a compound 26.3% a year; over ten years the rate was 15.8% a year. Across the 18 fiscal years on record (2009–2026), the highest was $1.52B in fiscal 2026 and the lowest $146.45M in fiscal 2009.

History · 18 fiscal years

Earnings (net income) by fiscal year

ResMed earnings, year by year

ResMed (RMD) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2026$1.52B 8.8% up
2025$1.40B 37.2% up
2024$1.02B 13.7% up
2023$897.56M 15.2% up
2022$779.44M 64.3% up
2021$474.51M 23.7% down
2020$621.67M 53.7% up
2019$404.59M 28.2% up
2018$315.59M 7.8% down
2017$342.28M 2.9% down
2016$352.41M 0.1% down
2015$352.89M 2.2% up
2014$345.27M 12.4% up
2013$307.13M 20.5% up
2012$254.85M 12.3% up
2011$226.99M 19.4% up
2010$190.09M 29.8% up
2009$146.45M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of ResMed and comparable companies
CompanyEarnings (net income)Fiscal year
Mettler-Toledo International MTD$869.19M2025
Centene CNC-$6.67B2025
Genmab GMAB$963.00M2025
Illumina ILMN$850.00M2025
ResMed RMD$1.52B2026
Zoetis ZTS$2.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed earnings: questions and answers

What is ResMed's net income?

ResMed (RMD) reported net income of $1.52B in fiscal 2026 (the year ended June 30, 2026). That is 8.8% higher than the $1.40B of fiscal 2025.

What is the growth rate of ResMed's net income?

Over the five fiscal years to 2026 net income grew at a compound 26.3% a year; over ten years the rate was 15.8% a year.

What are the highest and lowest net income figures on record for ResMed?

Across the 18 fiscal years on record (2009–2026), the highest was $1.52B in fiscal 2026 and the lowest $146.45M in fiscal 2009.

How is ResMed's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/RMD/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.